An interventional study of Analgesia and Analgesia in Gonarthrosis and Total Knee Arthroplasty, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-05.
Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 124 studies in Osteoarthritis, Knee with a site in France — 23 open to participants now, 33 under way, 1 of them phase 3. Osteoarthritis, Knee · France.
Among the 124 studies in Osteoarthritis, Knee with a site in France, this one is the 45th largest by planned enrollment of the 86 interventional ones that give a count, is one of 4 that started in 2026, is one of 58 with no phase, reaches primary completion later than 19 of the 32 other live ones, and was the 116th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →23 of the 124 studies in Osteoarthritis, Knee with a site in France are open now. Recruiting first, the newest first:
University Hospital, Brest · Sites in France
Ages 18–90
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 40–79
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18–70
CEN Biotech · Sites in France
Ages 50–80
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
124 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 10 · Phase 3 10 · Phase 4 6
First in 1999; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 106 across the 86 interventional studies, 100 across the 34 observational. Of the 73 that completed or were terminated, 7 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
38 of 124 have an industry lead sponsor. The 10 most frequent:
GCS Ramsay Santé pour l'Enseignement et la Recherche is the lead sponsor of 208 studies on the registry; 100 are open to participants now.
GCS Ramsay Santé pour l'Enseignement et la Recherche has 4 studies filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
8 of the studies in Osteoarthritis, Knee with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03522025Medacta International SAGMK-UNI Anatomical UKA: Fixation of Cemented vs Cementless Designs | 2026-12-01 |
| NCT06617975CEN BiotechKnee Osteoarthritis and Spa Therapy | 2026-12-15 |
| NCT07370480CEN BiotechKnee Osteoarthritis and Thermal Spa Treatment | 2027-02-10 |
| NCT05488093University Hospital, MontpellierEvaluation of Mobility in Subjects With Severe Knee Osteoarthritis Who Are to Undergo Total Knee Replacement | 2027-03 |
| NCT06676189University Hospital, Clermont-FerrandComparison of Pivotal Medial Polyethylene Versus Ultra-congruent in Total Knee Arthroplasty | 2027-03 |
Add all 8 to your calendar (.ics) → With an account.
Among the 124 studies in Osteoarthritis, Knee with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to evaluate the analgesic efficacy of this quadruple sensory block compared with the currently recommended procedure (adductor canal block + infiltration).
In addition to the adductor canal block, this quadruple block incorporates :
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Locoregional analgesia (LRA) protocol n°1 : adductor canal block + surgical infiltration (PROSPECT recommendations)
Procedure: Analgesia
Locoregional analgesia (LRA) protocol n° 2 : adductor canal block + femoral-cutaneous block + obturator block + IPACK block
Procedure: Analgesia
1- Real Adductor canal block + surgical infiltration and sham of femoro-cutaneous block + obturator block + IPACK block with physiological serum
2- Real Adductor canal block + femoral-cutaneous block + obturator block + IPACK block and sham of surgical infiltration with physiological serum
Patient's recovery at H24 as after surgery assessed by the QoR-15 (Quality of Recovery) questionnaire score
The QoR-15 score at H24 after surgery was compared between the two groups for primary endpoint analysis. The QoR-15 accurately measures postoperative recovery by focusing on 5 key domains: pain, physical comfort, physical independence, psychological support and emotional state. Each item is rated from 0 (unfavorable) to 10 (favorable), with an overall score corresponding to the sum of the score obtained for each item, i.e. a score from 0 (no recovery) to 150 (full recovery).
Time frame: From enrollement to the last H24 after surgery
Knee functional assessment
Functional assessment of the knee with KOOS JR questionnaire
Time frame: Hour 0
Post operative pain
Pain measured with a simple numeric scale
Time frame: Hour 2
Post operative pain
Pain measured with a simple numeric scale
Time frame: Hour 6
Post operative pain
Pain measured with a simple numeric scale
Time frame: Hour 12
First ambulation
time between end of intervention and first ambulation
Time frame: Hour 12
Post operative pain
Pain measured with a simple numeric scale
Time frame: Hour 24
Joint range of both knees
Measurement of the joint range of both knees
Time frame: Hour 24
First ambulation
time between end of intervention and first ambulation
Time frame: Hour 24
Post operative pain
Pain measured with a simple numeric scale
Time frame: Hour 48
Quality of recovery
Quality of recovery measured with QoR 15 questionnaire
Time frame: Hour 48
Opioid drug use
Opioid drug use evaluation
Time frame: Hour 48
Non-opioid drug use
Non-opioid drug use evaluation
Time frame: Hour 48
Joint range of both knees
Measurement of the joint range of both knees
Time frame: Hour 48
First ambulation
time between end of intervention and first ambulation
Time frame: Hour 48
Length of stay in the post-intervention monitoring room
Length of stay in the post-intervention monitoring room
Time frame: Hour 48
Post operative pain
Pain measured with a simple numeric scale
Time frame: Month 1
Joint range of both knees
Measurement of the joint range of both knees
Time frame: Month 1
Length of hospitalisation
Length of hospitalisation
Time frame: Month 1
Return to patient usual activities
Time taken for the patient to return to their usual activities
Time frame: Month 1
Drug tolerance
Drug tolerance
Time frame: Month 1
Patient comfort
Patient comfort during loco-regional anesthesia
Time frame: Hour 1
Knee functional assessment
Functional assessment of the knee with KOOS JR questionnaire
Time frame: Month 1
Plan to share: No
Started May 2026 (actual). Primary completion is estimated for May 2027, 12 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 12 months is below that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
GCS Ramsay Santé pour l'Enseignement et la Recherche →